MARKET

OXFD

OXFD

Oxford Immunotec
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.93
+0.55
+4.11%
Opening 14:06 07/09 EDT
OPEN
13.43
PREV CLOSE
13.38
HIGH
14.19
LOW
13.38
VOLUME
60.02K
TURNOVER
--
52 WEEK HIGH
17.77
52 WEEK LOW
8.37
MARKET CAP
361.43M
P/E (TTM)
-71.5460
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average OXFD stock price target is 18.50 with a high estimate of 21.00 and a low estimate of 16.00.

EPS

OXFD News

More
Hedge Funds Have Never Been This Bullish On Oxford Immunotec Global (OXFD)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These fi
Insider Monkey · 06/22 16:19
The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18)
Benzinga · 05/19 12:27
Oxford releases test that measures immune response to SARS-CoV-2
Seeking Alpha - Article · 05/19 10:43
Oxford Immunotec Global PLC's (OXFD) CEO Peter Wrighton-Smith on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/10 21:12
Oxford Immunotec Global PLC (OXFD) Q1 2020 Earnings Call Transcript
Motley Fool · 05/06 01:30
Soft outlook pressures Oxford Immunotec; shares down 10%
Oxford Immunotec Global PLC (OXFD -9.8%) is down, albeit on below-average volume, after releasing Q1 results that came in shy of expectations. The company
seekingalpha · 05/05 19:46
PTLA, TGTX, NCLH and HTZ among midday movers
Seeking Alpha - Article · 05/05 16:42
Oxford Immunotec Global EPS misses by $0.05, misses on revenue
Oxford Immunotec Global (NASDAQ:OXFD): Q1 GAAP EPS of -$0.20 misses by $0.05. Revenue of $13.91M (-5.9% Y/Y) misses by $0.09M. Press Release
seekingalpha · 05/05 16:09

Industry

Advanced Medical Equipment & Technology
-0.60%
Healthcare Equipment & Supplies
-0.23%

Hot Stocks

Symbol
Price
%Change

About OXFD

Oxford Immunotec Global PLC,is a diagnostics company. It is focused on developing and commercializing tests for under-served immune-regulated conditions. Its product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. It offers a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. Tick-borne disease is the collective name for diseases passed to humans through the bite of an infected tick. Its diagnostic tests for tick-borne infections include multiple laboratory developed tests (LDTs). Its tick-borne disease tests utilize molecular methods (such as polymerase chain reaction) and techniques to prosecute the immune system. It has a series of assays for use in blood screening, building upon its expertise in tick-borne disease.
More

Webull offers kinds of Oxford Immunotec Global PLC stock information, including NASDAQ:OXFD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OXFD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OXFD stock methods without spending real money on the virtual paper trading platform.